Alterations of retinoblastoma protein and p16(INK4) protein expression in extrahepatic bile duct carcinomas

Hepato-Gastroenterology

Volumn 47, Issue 35, 2000, Pages 1216-1220

  Cui, X ^a   Hui, A M ^a   Li, X ^a   Shi, Y Z ^a   Takayama, T ^a   Hatakeyama, K ^a   Makuuchi, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biliary tract cancer; P16(INK4); Retinoblastoma gene

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETINOBLASTOMA PROTEIN;

EID: 0033773706     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cell-cycle regulators and cancer
2. Cancer cell cycles
3. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
4. Mammalian G1 cyclins
5. Mutations and altered expression of p16(INK4) in human cancer
6. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16(INK4)
7. Rb and p16(INK4a) expression in resected non-small cell lung tumors
8. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
9. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
10. Inactivation of p16(INK4) in hepatocellular carcinoma
11. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
12. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors
13. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
14. Overexpression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma
15. Mutations of p16(INK4)/CDKN2 and p15(INK4B)/MTS2 genes in biliary tract cancers
16. Extrahepatic bile ducts
17. Prognostic value of the immunohistochemical detection of p16(INK4) expression in non-small cell lung carcinoma
18. Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression
19. Deletions of the cycline-dependent kinase-4 inhibitor gene in multiple human cancers
20. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16
21. High frequency of p16 (CDKN2/MTS-1/(INK4A)) inactivation in head and neck squamous cell carcinoma
22. Altered G1 phase regulation in osteosarcoma
23. Decreased p27(Kip) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma
24. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer
25. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma
26. p16 Inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis
27. Increased p16 levels correlate with pRb alterations in human urothelial cells
28. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study
29. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system